{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/077/SRR23355177/SRR23355177_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/081/SRR23355181/SRR23355181_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/076/SRR23355176/SRR23355176_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/080/SRR23355180/SRR23355180_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/064/SRR23355164/SRR23355164_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/065/SRR23355165/SRR23355165_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/053/SRR23355153/SRR23355153_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/052/SRR23355152/SRR23355152_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/078/SRR23355178/SRR23355178_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/050/SRR23355150/SRR23355150_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/062/SRR23355162/SRR23355162_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/051/SRR23355151/SRR23355151.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/066/SRR23355166/SRR23355166_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/080/SRR23355180/SRR23355180_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/059/SRR23355159/SRR23355159_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/054/SRR23355154/SRR23355154_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/067/SRR23355167/SRR23355167_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/057/SRR23355157/SRR23355157_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/055/SRR23355155/SRR23355155_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/082/SRR23355182/SRR23355182_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/060/SRR23355160/SRR23355160_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/058/SRR23355158/SRR23355158_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/054/SRR23355154/SRR23355154_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/069/SRR23355169/SRR23355169_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/081/SRR23355181/SRR23355181_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/052/SRR23355152/SRR23355152_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/066/SRR23355166/SRR23355166_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/061/SRR23355161/SRR23355161_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/064/SRR23355164/SRR23355164_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/063/SRR23355163/SRR23355163_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/070/SRR23355170/SRR23355170_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/073/SRR23355173/SRR23355173_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/079/SRR23355179/SRR23355179_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/075/SRR23355175/SRR23355175_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/078/SRR23355178/SRR23355178_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/076/SRR23355176/SRR23355176_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/072/SRR23355172/SRR23355172.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/057/SRR23355157/SRR23355157_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/071/SRR23355171/SRR23355171_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/069/SRR23355169/SRR23355169_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/083/SRR23355183/SRR23355183_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/067/SRR23355167/SRR23355167_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/079/SRR23355179/SRR23355179_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/056/SRR23355156/SRR23355156_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/055/SRR23355155/SRR23355155_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/068/SRR23355168/SRR23355168_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/074/SRR23355174/SRR23355174_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/056/SRR23355156/SRR23355156_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/070/SRR23355170/SRR23355170_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/060/SRR23355160/SRR23355160_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/068/SRR23355168/SRR23355168_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/082/SRR23355182/SRR23355182_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/083/SRR23355183/SRR23355183_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/075/SRR23355175/SRR23355175_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/053/SRR23355153/SRR23355153_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/071/SRR23355171/SRR23355171_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/063/SRR23355163/SRR23355163_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/065/SRR23355165/SRR23355165_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/077/SRR23355177/SRR23355177_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/050/SRR23355150/SRR23355150_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/074/SRR23355174/SRR23355174_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/073/SRR23355173/SRR23355173_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/062/SRR23355162/SRR23355162_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/061/SRR23355161/SRR23355161_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/058/SRR23355158/SRR23355158_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR233/059/SRR23355159/SRR23355159_2.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Crownbio"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA932157"],"long_description":["Defuse large B-cell lymphoma, the largest subtype of non-Hodgkin's lymphoma (NHL), are heterogeneous diseases with diverse histo-molecular pathology reflected by various subtypes genotypes, resulting in distinct pharmacology. Bruton tyrosine kinase inhibitors (BTKi) have yet to be approved for treating DLBCLs, mainly due to failure to identify the precise sensitive patient populations. We created a cohort of patient derived xenografts (PDXs) of diverse DLBCL diseases followed by detailed molecular pathology BTKi (ibrutinib) pharmacology analysis."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Molecular pathology and BTKi pharmacology of DLBCL patient-derived xenografts","dates":{"last_updated":"2024-07-19","first_public":"2024-05-11"},"accession":"PRJNA932157","cross_references":{}}